Isoalantolactone induces the apoptosis of oxaliplatin-resistant human colorectal cancer cells mediated by ROS generation and activation of JNK and p38 MAPK

Abstract Treating colorectal cancer (CRC) poses challenges due to the lack of specific molecular targets. Although oxaliplatin (Ox) is commonly used to treat CRC, resistance frequently develops, necessitating the discovery of new therapeutics. This study explored the anticancer effects of Isoalantol...

Full description

Saved in:
Bibliographic Details
Main Authors: Seung-On Lee, Sang Hoon Joo, Na Yeong Lee, Seung-Sik Cho, Goo Yoon, Ki-Taek Kim, Yung Hyun Choi, Jin Woo Park, Joon-Seok Choi, Jung-Hyun Shim
Format: Article
Language:English
Published: Nature Portfolio 2025-04-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-98499-7
Tags: Add Tag
No Tags, Be the first to tag this record!